Virbac Sa Stock Analysis
| VRBCF Stock | USD 346.00 0.00 0.00% |
Virbac SA holds a debt-to-equity ratio of 0.135. Virbac SA's financial risk is the risk to Virbac SA stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Virbac SA's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Virbac SA's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Virbac Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Virbac SA's stakeholders.
For many companies, including Virbac SA, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Virbac SA, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Virbac SA's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Virbac SA's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Virbac SA is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Virbac SA to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Virbac SA is said to be less leveraged. If creditors hold a majority of Virbac SA's assets, the Company is said to be highly leveraged.
Virbac SA is fairly valued with Real Value of 346.0 and Hype Value of 346.0. The main objective of Virbac SA pink sheet analysis is to determine its intrinsic value, which is an estimate of what Virbac SA is worth, separate from its market price. There are two main types of Virbac SA's stock analysis: fundamental analysis and technical analysis.
The Virbac SA pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Virbac SA's ongoing operational relationships across important fundamental and technical indicators.
Virbac |
Virbac Pink Sheet Analysis Notes
About 50.0% of the company outstanding shares are owned by insiders. The book value of Virbac SA was at this time reported as 96.99. The company recorded earning per share (EPS) of 13.65. Virbac SA last dividend was issued on the 24th of June 2022. The entity had 4:1 split on the 30th of July 2002. Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Virbac SA was founded in 1968 and is headquartered in Carros, France. Virbac Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 5120 people.The quote for Virbac SA is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call Marc Bistuer at 33 4 92 08 71 00 or visit https://corporate.virbac.com.Virbac SA Investment Alerts
| Virbac SA generated a negative expected return over the last 90 days | |
| About 50.0% of the company outstanding shares are owned by insiders |
Virbac Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.38 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Virbac SA's market, we take the total number of its shares issued and multiply it by Virbac SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Virbac Profitablity
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.16 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.16.Technical Drivers
In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Virbac SA, as well as the relationship between them.Virbac SA Price Movement Analysis
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Virbac SA price series with the more recent values given greater weights.
Virbac SA Debt to Cash Allocation
Many companies such as Virbac SA, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Virbac SA has accumulated 13.15 M in total debt with debt to equity ratio (D/E) of 0.14, which may suggest the company is not taking enough advantage from borrowing. Virbac SA has a current ratio of 1.65, which is within standard range for the sector. Debt can assist Virbac SA until it has trouble settling it off, either with new capital or with free cash flow. So, Virbac SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Virbac SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Virbac to invest in growth at high rates of return. When we think about Virbac SA's use of debt, we should always consider it together with cash and equity.Virbac SA Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Virbac SA's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Virbac SA, which in turn will lower the firm's financial flexibility.About Virbac Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Virbac SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Virbac shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Virbac SA. By using and applying Virbac Pink Sheet analysis, traders can create a robust methodology for identifying Virbac entry and exit points for their positions.
Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. Virbac SA was founded in 1968 and is headquartered in Carros, France. Virbac Sa operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 5120 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Virbac SA to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Anywhere Now
Portfolio AnywhereTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Complementary Tools for Virbac Pink Sheet analysis
When running Virbac SA's price analysis, check to measure Virbac SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virbac SA is operating at the current time. Most of Virbac SA's value examination focuses on studying past and present price action to predict the probability of Virbac SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Virbac SA's price. Additionally, you may evaluate how the addition of Virbac SA to your portfolios can decrease your overall portfolio volatility.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |